FDA fast-tracks NeuroVive's traumatic brain injury drug

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review.

Vertex’ chief Leiden to step down, with CMO named successor

Symonds confirmed as new GSK chairman amid CEO's business re...

GlaxoSmithKline has confirmed that it has hired Jonathan Symonds as chairman, confirming press speculation that the former Novartis and AstraZeneca finance chief was in the frame to replace

Intec Pharma shares dive after Parkinson's trial failure

Intec Pharma’s Parkinson’s gradual release disease drug trial has missed its primary endpoint, causing the biotech’s share price to crash.

AI specialist Exscientia forms rare disease JV with RallyBio

ViiV’s first-in-class HIV drug on course for filings this ye...